Bookbuilding IPO | ₹411 Cr | Listed at BSE, NSE | Wed, Jul 20, 2016 - Fri, Jul 22, 2016
Advanced Enzyme Technologies IPO is a book build issue of ₹411.49 crores. The issue is a combination of fresh issue of 0.06 crore shares aggregating to ₹50.19 crores and offer for sale of 0.40 crore shares aggregating to ₹361.30 crores.
Advanced Enzyme Technologies IPO bidding started from Jul 20, 2016 and ended on Jul 22, 2016. The shares got listed on BSE, NSE on Aug 1, 2016.
Advanced Enzyme Technologies IPO price band is set at ₹896 per share. The lot size for an application is 16. The minimum amount of investment required by an retail is ₹14,336 (16 shares) (based on upper price). The lot size investment for sNII is 14 lots (224 shares), amounting to ₹2,00,704, and for bNII, it is 70 lots (1,120 shares), amounting to ₹10,03,520.
The issue includes a reservation of up to 24,691 shares for employees offered at a discount of ₹86.00 to the issue price.
Axis Capital Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Advanced Enzyme Technologies IPO RHP for detailed Information.
IPO Open
Wed, Jul 20, 2016
IPO Close
Fri, Jul 22, 2016
Issue Price
₹896 per share
Market Cap (Pre-IPO)
₹2,000.41 Cr
| IPO Date | 20 to 22 Jul, 2016 |
| Listed on | Mon, Aug 1, 2016 |
| Face Value | ₹10 per share |
| Price Band | ₹880 to ₹896 |
| Issue Price | ₹896 per share |
| Lot Size | 16 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Employee Discount | ₹86.00 |
| Total Issue Size | 45,94,875 shares (agg. up to ₹411 Cr) |
| Fresh Issue | 5,60,405 shares (agg. up to ₹50 Cr) |
| Offer for Sale | 40,34,470 shares of ₹10 (agg. up to ₹361 Cr) |
| Share Holding Pre Issue | 2,17,65,600 shares |
| Share Holding Post Issue | 2,23,26,005 shares |
| BSE Script Code / NSE Symbol | 540025 / ADVENZYMES |
| ISIN | INE837H01012 |
Advanced Enzyme Technologies IPO comprises a total issue size of 45,94,875 shares. The net offer to the public is 45,70,184 shares, after excluding 24,691 shares under a preferential allotment. Of the Net offer 22,85,091 (50.00%) are allocated to QIB, 6,85,528 (15.00%) allocated to NII 15,99,565 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue | Max Allottees |
|---|---|---|---|---|
| QIB Shares Offered | 22,85,091 | 50.00% | 49.73% | NA |
| − Anchor Investor Shares Offered | 13,71,053 | 29.84% | NA | |
| − QIB (Ex. Anchor) Shares Offered | 9,14,038 | 19.89% | NA | |
| NII (HNI) Shares Offered | 6,85,528 | 15.00% | 14.92% | NA |
| Retail Shares Offered | 15,99,565 | 35.00% | 34.81% | 99,972 |
| Preferential Reservations | ||||
| Employee Shares Offered | 24,691 | 0.54% | NA | |
| Total Shares Offered | 45,94,875 | 100.00% | 100.00% | |
Investors can bid for a minimum of 16 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 16 | ₹14,336 |
| Retail (Max) | 13 | 208 | ₹1,86,368 |
| S-HNI (Min) | 14 | 224 | ₹2,00,704 |
| S-HNI (Max) | 69 | 1,104 | ₹9,89,184 |
| B-HNI (Min) | 70 | 1,120 | ₹10,03,520 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products. Information in this paragraph is copied from chittorgarh.com.
Company produces over 400 proprietary products developed from 60 enzymes. Advanced Enzyme operate in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food).
Company has 13 patents registered in its name and applications for registration of 4 patents are pending.
Advanced Enzyme is among top 15 companies in enzyme sales in the world and 2nd largest in India. Company has over 20 years of fermentation experience in the production of enzymes. Company offer these products to its more than 700 global customers across 50 countries around the world. Content in this paragraph is copied from chittorgarh.com.
Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company have four R&D facilities, of which two are located at Thane, and one each at Sinnar and Chino, California.
Competitive strengths of the company:
1. Integrated Company with presence across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in Advanced Enzymes USA, the wholly owned subsidiary for repayment/pre-payment of certain loans availed by Advanced Enzymes USA | 40.00 |
| 2 | General corporate purpose | 7.20 |
| KPI | |
|---|---|
| RoNW | 28.14% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 63.11% | 49.52% |
| Market Cap | ₹2,000.41 Cr. |
The Advanced Enzyme IPO is subscribed 116.02 times on July 22, 2016 5:00:00 PM (Day 3). The public issue subscribed 11.67 times in the retail category, 94.03 times in the QIB category, and 393.1 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 94.03 | 9,18,908 | |
| NII | 393.1 | 6,86,989 | |
| Retail | 11.67 | 16,02,974 | |
| Employee | 1.73 | 25,188 | |
| Total | 116.02 | 32,34,059 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLMs’ fees, Registrar's fees, Underwriting commissions, brokerages and selling commissions | 123.68 |
| 2 | Commission and processing fee for SCSBs | 7.48 |
| 3 | Brokerage and selling commission including for Registered Brokers, RTAs and DPs and bidding charges | 11.82 |
| 4 | Advertising and marketing expenses, printing, stationery and distribution expenses | 26.24 |
| 5 | SEBI processing fees, listing fees and other costs associated with listing including processing fees of Stock Exchanges, bidding software expenses, depository charges, STT etc. | 15.77 |
| 6 | Others (Auditors’ fees, legal fees etc.) | 24.50 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹896.00 | ₹896.00 |
| Open | ₹1,210.00 | ₹1,210.00 |
| Low | ₹1,168.55 | ₹1,168.00 |
| High | ₹1,242.75 | ₹1,244.00 |
| Last Trade | ₹1,178.30 | ₹1,178.10 |
Lead Manager Reports
Advanced Enzyme Technologies IPO is a main-board IPO of 45,94,875 equity shares of the face value of ₹10 aggregating up to ₹411 Crores. The issue is priced at ₹896 per share. The minimum order quantity is 16.
The IPO opens on Wed, Jul 20, 2016, and closes on Fri, Jul 22, 2016.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Advanced Enzyme Technologies IPO using UPI as a payment gateway. Zerodha customers can apply in Advanced Enzyme Technologies IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Advanced Enzyme Technologies IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Advanced Enzyme Technologies IPO opens on Wed, Jul 20, 2016 and closes on Fri, Jul 22, 2016.
Advanced Enzyme Technologies IPO lot size is 16, and the minimum amount required for application is ₹14,336.
You can apply in Advanced Enzyme Technologies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Advanced Enzyme Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Advanced Enzyme Technologies IPO allotment status.
The Advanced Enzyme Technologies IPO listing date is on Mon, Aug 1, 2016.
